Vox Sanguinis· 2026Q2

Inter‐institutional perspectives on usage of fibrinogen replacement therapies in North America

Cindy Tay, Laura D. Stephens, Wen Lu, Kerry O'Brien et al.

0citations
Q2SCImago
2026year

Short summary

A survey of 53 North American institutions found that 58.5% exclusively use cryoprecipitate for fibrinogen replacement, with over half restricting fibrinogen concentrate (FC) use primarily due to cost concerns.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Critical Care and Intensive Care Medicine

Critical Care and Intensive Care MedicineMedicine